Two German biotechs, BioNTech and CureVac, have been at the cutting edge of the hunt for a COVID-19 vaccine—a time-consuming and costly process. In order to get both over the finish line, the German government is making a big investment in both candidates’ development. The German government has awarded the mRNA-based vaccine makers a combined… Read More »
Oxford and AstraZeneca’s COVID vaccine trial is put on HOLD as British volunteer has ‘serious’ reaction ‘that triggered spinal cord infection’ Worldwide trials of jab paused indefinitely after British patient rushed to hospital Thought to have suffered serious spinal cord infection, according to sources Investigation launched to tell if vaccine caused the side effect or… Read More »
Although median ratios for U.S. not-for-profit hospitals and health systems improved in its 2020 report, analysts from Fitch Ratings say that financial effects of the coronavirus pandemic will be felt in the future. In 2020 Median Ratios for Not-for-Profit Hospitals and Healthcare Systems, the credit rating firm found that operating margins and operating EBITDA increased… Read More »
Amid daily headlines about COVID-19 vaccines and trends, Gilead’s Veklury, also known as remdesivir, remains the only antiviral drug authorized to treat the illness. With a new move from the FDA, the medicine’s emergency green light is a little broader—despite some lingering questions about its efficacy. Under the expanded emergency use authorization (EUA), all hospitalized… Read More »